1-16 of 16
Keywords: Everolimus
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Neuroendocrinology (2022) 112 (1): 34–42.
Published Online: 12 January 2021
... (everolimus or temozolomide). Advanced PanNET patients treated at our center from 1992 to 2013 were retrospectively reviewed. Patients received bolus 5-FU (400 mg/m 2 ), streptozocin (400 mg/m 2 ) (both IV, days 1–5), and doxorubicin (40 mg/m 2 IV, day 1) every 28 days. Overall response rate (ORR...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Neuroendocrinology (2017) 104 (3): 209–222.
Published Online: 16 April 2016
...-effects model, with studies pooled according to drug class and/or control arm for clinical homogeneity. Results: Fifteen RCT [SSA, n = 2; mammalian target of rapamycin (mTOR)/VEGF inhibitors, n = 4; IFN, n = 3; targeted therapy added to everolimus, n = 2, and other, n = 4] investigating 2,790 patients...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Neuroendocrinology (2010) 92 (Suppl. 1): 28–34.
Published Online: 10 September 2010
... Everolimus Adrenal tumors include benign and malignant cortical tumors and benign and malignant pheochromocytomas [ 1 ]. The malignant adrenal tumors are aggressive tumors with a poor prognosis [ 2,3,4,5 ]. The surgical removal of the tumor represents the treatment of choice for both benign...